4.5 Review

Sex differences and estrogen modulation of the cellular immune response after injury

期刊

CELLULAR IMMUNOLOGY
卷 252, 期 1-2, 页码 57-67

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2007.09.007

关键词

estrogen; testosterone; macrophage; neutrophil; T cell; injury; burn; trauma-hemorrhage; cytokines; immunity; inflammation

资金

  1. National Institutes of Health [AA12034, AG18859, T32 AA 13527]
  2. Ralph and Marion C. Falk Foundation
  3. Illinois Excellence in Academic Medicine Grant
  4. NATIONAL INSTITUTE ON AGING [R01AG018859] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA017027, R01AA012034, T32AA013527] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Cell-mediated immunity is extremely important for resolution of infection and for proper healing from injury. However, the cellular immune response is dysregulated following injuries such as burn and hemorrhage. Sex hormones are known to regulate immunity, and a well-documented dichotomy exists in the immune response to injury between the sexes. This disparity is caused by differences in immune cell activation, infiltration, and cytokine production during and after injury. Estrogen and testosterone can positively or negatively regulate the cellular immune response either by aiding in resolution or by compounding the morbidity and mortality. It is apparent that the hormonal dysregulation is dependent not only on the type of injury sustained but also the amount of circulating hormones. Therefore, it may be possible to design sex-specific therapies to improve immunological function and patient outcome. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Cell Biology

Loss of B1 and marginal zone B cells during ovarian cancer

Jeffrey Maslanka, Gretel Torres, Jennifer Londregan, Naomi Goldman, Daniel Silberman, John Somerville, James E. Riggs

Summary: This study investigates the immunobiology of the peritoneum in ovarian cancer, revealing reduced B1 cells in the ascites and selective loss of B1 and marginal zone B cell subsets in the spleen. These findings suggest a correlation between the depletion of B cell subsets and the influx of myeloid-derived suppressor cells during ovarian cancer.

CELLULAR IMMUNOLOGY (2024)